Incidence of GM-CSF Antibodies in Cancer Patients Receiving GM-CSF for Immunostimulation

By Ullenhag G.   Bird C.   Ragnhammar P.   Frödin J-E.   Strigård K.   Österborg A.   Thorpe R.   Mellstedt H.   Wadhwa M.  

Clinical Immunology, Vol. 99, Iss. 1, 2001-04 ,pp. : 65-74

Academic Press

Access to resources Recommend Favorite

Effect of M-CSF, GM-CSF in adenovirus-mediated gene transfer into macrophages

By Shinozuka N.   Kamisasa N.   Akaishi T.   Minoshima T.   Watanabe T.   Matsumoto T.   Anzai H.   Koyama I.   Kyo S.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 963-963

Elsevier

Access to resources Recommend Favorite

Use of rHu GM-CSF in Renal-Transplant Patients Developing Leukopenia

By Hashmi A.   Hussain M.   Hussain Z.   Ahmed E.   Shamsi T.   Naqvi R.   Ali B.   Mehdi H.   Mohsin R.   Naqvi A.   Rizvi A.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 3053-3053

Elsevier

Access to resources Recommend Favorite

Anti-GM-CSF Titer Predicts Response to GM-CSF Therapy in Pulmonary Alveolar Proteinosis

By Bonfield T.L.   Kavuru M.S.   Thomassen M.J.  

Clinical Immunology, Vol. 105, Iss. 3, 2002-12 ,pp. : 342-350

Academic Press

Access to resources Recommend Favorite

Granulocyte macrophage colony stimulating factor (GM-CSF) activity is regulated by a GM-CSF binding molecule in Wallerian degeneration following injury to peripheral nerve axons

By Mirski R.   Reichert F.   Klar A.   Rotshenker S.  

Journal of Neuroimmunology, Vol. 140, Iss. 1, 2003-07 ,pp. : 88-96

Elsevier

Access to resources Recommend Favorite